| Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting K Frontzek, MI Lutz, A Aguzzi, GG Kovacs, H Budka Swiss medical weekly 146, w14287, 2016 | 166 | 2016 |
| Inflammatory olfactory neuropathy in two patients with Covid-19 D Kirschenbaum, LL Imbach, S Ulrich, EJ Rushing, E Keller, RR Reimann, ... The Lancet 396 (10245), 166, 2020 | 131 | 2020 |
| The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients Ö Yaldizli, IK Penner, K Frontzek, Y Naegelin, M Amann, A Papadopoulou, ... Multiple Sclerosis Journal 20 (3), 356-364, 2014 | 129 | 2014 |
| Intracerebral endotheliitis and microbleeds are neuropathological features of COVID‐19 D Kirschenbaum, LL Imbach, EJ Rushing, KBM Frauenknecht, D Gascho, ... Neuropathology and applied neurobiology 47 (3), 454-459, 2021 | 123 | 2021 |
| Large and small cerebral vessel involvement in severe COVID-19 E Keller, G Brandi, S Winklhofer, LL Imbach, D Kirschenbaum, K Frontzek, ... Stroke, 2020 | 112 | 2020 |
| CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo M Koch, F Hussein, A Woeste, C Gründker, K Frontzek, G Emons, ... Breast cancer research and treatment 128, 337-346, 2011 | 109 | 2011 |
| 68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate? M Sommerauer, JK Burkhardt, K Frontzek, E Rushing, A Buck, ... Neuro-oncology 18 (7), 1021-1027, 2016 | 97 | 2016 |
| Toward therapy of human prion diseases A Aguzzi, AKK Lakkaraju, K Frontzek Annual review of pharmacology and toxicology 58 (1), 331-351, 2018 | 84 | 2018 |
| COVID-19 targets human adrenal glands W Kanczkowski, K Evert, M Stadtmüller, M Haberecker, L Laks, LS Chen, ... The Lancet Diabetes & Endocrinology 10 (1), 13-16, 2022 | 70 | 2022 |
| Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study E Jones, H Hummerich, E Viré, J Uphill, A Dimitriadis, H Speedy, ... The Lancet Neurology 19 (10), 840-848, 2020 | 63 | 2020 |
| Case report: encephalitis, with brainstem involvement, following checkpoint inhibitor therapy in metastatic melanoma S Bossart, S Thurneysen, E Rushing, K Frontzek, H Leske, D Mihic‐Probst, ... The oncologist 22 (6), 749-753, 2017 | 46 | 2017 |
| Autopsy-based pulmonary and vascular pathology: pulmonary endotheliitis and multi-organ involvement in COVID-19 associated deaths M Haberecker, EI Schwarz, P Steiger, K Frontzek, F Scholkmann, X Zeng, ... Respiration 101 (2), 155-165, 2022 | 41 | 2022 |
| SARM1 deficiency up-regulates XAF1, promotes neuronal apoptosis, and accelerates prion disease C Zhu, B Li, K Frontzek, Y Liu, A Aguzzi Journal of Experimental Medicine 216 (4), 743-756, 2019 | 36 | 2019 |
| Loss of PIKfyve drives the spongiform degeneration in prion diseases AKK Lakkaraju, K Frontzek, E Lemes, U Herrmann, M Losa, R Marpakwar, ... EMBO molecular medicine 13 (9), 1-17, 2021 | 35 | 2021 |
| Isolated insular strokes and plasma MR-proANP levels are associated with newly diagnosed atrial fibrillation: a pilot study K Frontzek, F Fluri, J Siemerkus, B Müller, A Gass, M Christ-Crain, ... PLoS One 9 (3), e92421, 2014 | 29 | 2014 |
| A conformational switch controlling the toxicity of the prion protein K Frontzek, M Bardelli, A Senatore, A Henzi, RR Reimann, S Bedir, ... Nature Structural & Molecular Biology 29 (8), 831-840, 2022 | 27 | 2022 |
| Long-term persisting SARS-CoV-2 RNA and pathological findings: lessons learnt from a series of 35 COVID-19 autopsies U Maccio, AS Zinkernagel, R Schuepbach, E Probst-Mueller, K Frontzek, ... Frontiers in Medicine 9, 778489, 2022 | 26 | 2022 |
| Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies L Linsenmeier, B Mohammadi, M Shafiq, K Frontzek, J Bär, ... Science advances 7 (48), eabj1826, 2021 | 26 | 2021 |
| A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicity M Bardelli, K Frontzek, L Simonelli, S Hornemann, M Pedotti, F Mazzola, ... PLoS pathogens 14 (10), e1007335, 2018 | 26 | 2018 |
| Neurotoxic antibodies against the prion protein do not trigger prion replication K Frontzek, M Pfammatter, S Sorce, A Senatore, P Schwarz, R Moos, ... PloS one 11 (9), e0163601, 2016 | 26 | 2016 |
